Today, Viora, a leading medical aesthetics provider, announced another successful year setting record profitability and growth levels during 2017. Much of the success was fueled by Viora’s V-Series platform that enabled partners to perform a wide array of treatments with excellent clinical results, thanks to the V-Series advanced technologies.
Viora Continues to deliver on its strategy of forming lasting relationships with its family of providers; Viora succeeded in addressing the needs of its partners by providing exceptional support and tools to further safeguard success in the booming medical aesthetic segment.
“We have always been passionate about building sustainable, long-term partnerships and helping to deliver enhanced clinical outcomes,” said Eliran Almog, CEO, Viora Ltd. “The strong profitability and growth have been a genuine indicator of how successful this philosophy has been for us, and we will continue to invest in helping our partnerships flourish.”
Throughout 2017, Viora offered upgrade opportunities from renowned Reaction devices to their current flagship, V-Series. Viora also delivered on promises to add functionality and treatment capabilities to the V-Series line with the addition of the medium applicator, for the V-FORM handpiece (available on V10, V20, and V30).
Additionally, during Q4 2016, Viora moved to a new corporate office in Manhattan, New York, where the company was founded over 12 years ago. Viora also made the exciting appointment of Sally Gibb as National Sales Director. The appointment came after her extensive contribution and involvement in fostering an increasing number of affiliates within Viora's network.
“When the V-Series launched in 2015, we promised a flexible solution with superior results from an expandable service that grows with your practice,” said Andrea Trofimuk, CEO, Viora Inc. “I am immensely proud to have delivered on our promise with V-Series, and our shared accomplishments achieved with our customers. It’s an excellent example of a meaningful, mutual partnership and we have become a truly global family”.
The success of 2017 has positioned Viora for a prosperous 2018, having already begun to invest back into strategic and clinical enhancements for the V-Series line which continues to enjoy new clinical capabilities and developments. Viora is also strongly positioned to maintain its expansion into new industry verticals and establish greater regional authority.
Viora is a market-leading aesthetic solutions provider for skincare applications for patients seeking the most advanced developments for the most requested treatments: skin rejuvenation, resurfacing, body & facial contouring, skin therapy, cellulite reduction, acne control, skin lightening, hydration, hair removal, pigmentation and vascular clearance, exfoliation and more. Viora’s expertise in developing solutions and technology for these applications ensures greater physician and client satisfaction. Viora’s extensive knowledge and experience is forged from its expansive and deep connections to the aesthetic community and has allowed Viora to create the most sought-after solutions, and achieve the most effective results. For more information, visit: http://www.vioramed.com